Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carl H June

Showing results (411-420 of 460) with videos related to

Pageof 46
Sort By:
Nature Biomedical Engineering|October 21, 2025
CCR5-targeted allogeneic gamma-delta CD19 chimeric antigen receptor T cells for HIV-associated B cell-malignancy immunotherapyÁngel Ramírez-Fernández, Alexander J Dimitri, Fang Chen, et al.
Nature Medicine|October 18, 2005
Restoration of immunity in lymphopenic individuals with cancer by vaccination and adoptive T-cell transferAaron P Rapoport, Edward A Stadtmauer, Nicole Aqui, et al.
Plos Pathogens|May 3, 2011
Engineering HIV-resistant human CD4+ T cells with CXCR4-specific zinc-finger nucleasesCraig B Wilen, Jianbin Wang, John C Tilton, et al.
Blood Advances|March 29, 2022
Anti-CD19 CAR T cells in combination with ibrutinib for the treatment of chronic lymphocytic leukemiaSaar Gill, Vanessa Vides, Noelle V Frey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 14, 2015
High-Dose Sirolimus and Immune-Selective Pentostatin plus Cyclophosphamide Conditioning Yields Stable Mixed Chimerism and Insufficient Graft-versus-Tumor ResponsesMiriam E Mossoba, David C Halverson, Roger Kurlander, et al.
Journal for Immunotherapy of Cancer|August 6, 2021
Pooled safety analysis of tisagenlecleucel in children and young adults with B cell acute lymphoblastic leukemiaJohn E Levine, Stephan A Grupp, Michael A Pulsipher, et al.
The Journal of Clinical Investigation|February 11, 2021
CCR5-edited CD4+ T cells augment HIV-specific immunity to enable post-rebound control of HIV replicationPablo Tebas, Julie K Jadlowsky, Pamela A Shaw, et al.
Blood|January 28, 2016
Ibrutinib enhances chimeric antigen receptor T-cell engraftment and efficacy in leukemiaJoseph A Fraietta, Kyle A Beckwith, Prachi R Patel, et al.
The Journal of Clinical Investigation|May 1, 2024
CCR5-edited CD4+ T cells augment HIV-specific immunity to enable post-rebound control of HIV replicationPablo Tebas, Julie K Jadlowsky, Pamela A Shaw, et al.
Science Translational Medicine|April 13, 2018
Personalized cancer vaccine effectively mobilizes antitumor T cell immunity in ovarian cancerJanos L Tanyi, Sara Bobisse, Eran Ophir, et al.
Pageof 46

Showing results (411-420 of 460) with videos related to

Sort By:
Pageof 46
Nature Biomedical Engineering|October 21, 2025
CCR5-targeted allogeneic gamma-delta CD19 chimeric antigen receptor T cells for HIV-associated B cell-malignancy immunotherapyÁngel Ramírez-Fernández, Alexander J Dimitri, Fang Chen, et al.
Nature Medicine|October 18, 2005
Restoration of immunity in lymphopenic individuals with cancer by vaccination and adoptive T-cell transferAaron P Rapoport, Edward A Stadtmauer, Nicole Aqui, et al.
Plos Pathogens|May 3, 2011
Engineering HIV-resistant human CD4+ T cells with CXCR4-specific zinc-finger nucleasesCraig B Wilen, Jianbin Wang, John C Tilton, et al.
Blood Advances|March 29, 2022
Anti-CD19 CAR T cells in combination with ibrutinib for the treatment of chronic lymphocytic leukemiaSaar Gill, Vanessa Vides, Noelle V Frey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 14, 2015
High-Dose Sirolimus and Immune-Selective Pentostatin plus Cyclophosphamide Conditioning Yields Stable Mixed Chimerism and Insufficient Graft-versus-Tumor ResponsesMiriam E Mossoba, David C Halverson, Roger Kurlander, et al.
Journal for Immunotherapy of Cancer|August 6, 2021
Pooled safety analysis of tisagenlecleucel in children and young adults with B cell acute lymphoblastic leukemiaJohn E Levine, Stephan A Grupp, Michael A Pulsipher, et al.
The Journal of Clinical Investigation|February 11, 2021
CCR5-edited CD4+ T cells augment HIV-specific immunity to enable post-rebound control of HIV replicationPablo Tebas, Julie K Jadlowsky, Pamela A Shaw, et al.
Blood|January 28, 2016
Ibrutinib enhances chimeric antigen receptor T-cell engraftment and efficacy in leukemiaJoseph A Fraietta, Kyle A Beckwith, Prachi R Patel, et al.
The Journal of Clinical Investigation|May 1, 2024
CCR5-edited CD4+ T cells augment HIV-specific immunity to enable post-rebound control of HIV replicationPablo Tebas, Julie K Jadlowsky, Pamela A Shaw, et al.
Science Translational Medicine|April 13, 2018
Personalized cancer vaccine effectively mobilizes antitumor T cell immunity in ovarian cancerJanos L Tanyi, Sara Bobisse, Eran Ophir, et al.
Pageof 46